Captamine

Captamine

SCHEMBL126014

CN(C)CCS.Cl

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Captamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Captamine SCHEMBL28183461 0.96
Captamine SCHEMBL258800 0.96
Captamine SCHEMBL10386744 0.92
Captamine SCHEMBL8411585 0.92
Captamine SCHEMBL11869601 0.92 TDP1 (0.92)
Captamine SCHEMBL9709132 0.92
Captamine SCHEMBL28091581 0.88
Captamine SCHEMBL2244968 0.88
Hydrochloric Acid SCHEMBL6057729 0.77
Captamine SCHEMBL4576750 0.77 TDP1 (0.65)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1076 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617754-B2 Process for synthesizing lipids BRISTOL-MYERS SQUIBB COMPANY (US) 2026-05-05 US claimed
EP-4171579-B1 PROCESS FOR SYNTHESIZING LIPIDS BRISTOL MYERS SQUIBB CO (US) 2026-02-25 EP claimed
US-20250126975-A1 DISPLAY DEVICE AND METHOD FOR MANUFACTURING DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2025-04-17 US claimed
US-20240400558-A1 PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB MIRATI THERAPEUTICS, INC 2024-12-05 US claimed
US-20240276748-A1 ELECTRONIC DEVICE AND METHOD OF PRODUCING ELECTRONIC DEVICE SHARP KABUSHIKI KAISHA (JP) 2024-08-15 US claimed
EP-4398897-A1 PROCESSES AND INTERMEDIATES FOR SYNTHESIS OF ADAGRASIB Mirati Therapeutics, Inc. (US) 2024-07-17 EP claimed
CN-115850137-B Pleuromutilin derivative compound and preparation method and application thereof 中国农业科学院兰州畜牧与兽药研究所 2024-04-12 CN claimed
CN-117603146-A Pleuromutilin derivative, preparation method and application thereof 河北科技大学 2024-02-27 CN claimed
US-20230303918-A1 METHOD OF EXCHANGING LIGANDS, QUANTUM DOT COMPOSITION, AND ELECTROLUMINESCENT ELEMENT SHARP KABUSHIKI KAISHA (JP) 2023-09-28 US claimed
US-20230250056-A1 PROCESS FOR SYNTHESIZING LIPIDS BRISTOL-MYERS SQUIBB COMPANY 2023-08-10 US claimed
CN-103675295-B Based on the protein pattern recognition methods of micro-cantilever platform Shanghai National Engineering Research Center for Nanotechnology Co., Ltd. (CN) 2015-10-28 CN claimed
CN-104251853-A Method for detecting perchlorate radical in water by using surface enhanced Raman scattering technology SUZHOU GIANT OPTIC TECHNOLOGY CO LTD 2014-12-31 CN claimed
CN-103675295-A Protein pattern identification method based on microcantilever platform SH NAT ENG RES CT NANOTECH CO 2014-03-26 CN claimed
CN-102432510-B Synthetic method of dimethyl cysteamine hydrochloride SHANDONG SHENGLI CO LTD 2014-02-12 CN claimed
CN-103382172-A Synthesis method for valnemulin hydrochloride LANZHOU INST ANIMAL SCIENCE & VETERINARY PHARMACEUTICS CAAS 2013-11-06 CN claimed
CN-102924350-A Pleuromutilin derivatives, and preparation method and application thereof LANZHOU INST ANIMAL SCIENCE & VETERINARY PHARMACEUTICS CAAS 2013-02-13 CN claimed
US-20120315304-A1 SENSITIZATION OF IMMUNE SYSTEM AGAINST HAPTENIZED MELANOMA ANTIGENS ACADEMISCH ZIEKENHUIS LEIDEN (NL) 2012-12-13 US claimed
US-6958208-B2 Methods of providing color photographic image using acidic stop and rinse solutions EASTMAN KODAK COMPANY (US) 2005-10-25 US claimed
WO-2005045520-A2 METHODS OF PROVIDING COLOR PHOTOGRAPHIC IMAGE EASTMAN KODAK COMPANY (US) 2005-05-19 WO claimed
US-20050094996-A1 Methods of providing color photographic image using acidic stop and rinse solutions EASTMAN KODAK COMPANY 2005-05-05 US claimed